期刊
JOURNAL OF FUNGI
卷 7, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/jof7030174
关键词
mucormycosis; COVID-19; pneumonia; Rhizopus
This case report highlights a rare case of COVID-19 patient with Rhizopus azygosporus pneumonia, emphasizing the potential risk of mucormycosis with the use of immunosuppressants. It underscores the importance of vigilance in monitoring hospitalized COVID-19 patients for fungal infections.
We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据